(12) International Application Status Report

Received at International Bureau: 03 February 2005 (03.02.2005)

Information valid as of: Not available

Report generated on: 14 December 2019 (14.12.2019)

(10) Publication number: (43) Publication date: (26) Publication language:
WO 2005/06328814 July 2005 (14.07.2005) English (EN)

(21) Application number: (22) Filing date: (25) Filing language:
PCT/EP2004/01463022 December 2004 (22.12.2004) English (EN)

(31) Priority number(s): (32) Priority date(s): (33) Priority status:
03029801.2 (EP)23 December 2003 (23.12.2003) Priority document received (in compliance with PCT Rule 17.1)

(51) International Patent Classification:
A61K 9/127 (2006.01); A61K 39/00 (2006.01); A61K 39/39 (2006.01)

(71) Applicant(s):
PHARMEXA A/S [DK/DK]; Kogle Allé 6 DK-2970 Horsholm (DK) (for all designated states except US)
KONUR, Abdo [DE/DE]; Cilly-Schäfer-Strasse 28 35037 Marburg (DE) (for US only)
GRASER, Andreas [DE/DE]; Füllenplatz 18 79618 Rheinfelden (Baden) (DE) (for US only)

(72) Inventor(s):
KONUR, Abdo; Cilly-Schäfer-Strasse 28 35037 Marburg (DE)
GRASER, Andreas; Füllenplatz 18 79618 Rheinfelden (Baden) (DE)

(74) Agent(s):
ZWICKER, Jörk; Dr. Volker Vossius Geibelstrasse 6 81679 München (DE)

(54) Title (EN): SYNERGISTIC LIPOSOMAL ADJUVANTS
(54) Title (FR): ADJUVANTS LIPOSOMAUX SYNERGIQUES

(57) Abstract:
(EN): The present invention relates to liposome, mixtures or liposomes and liposomal compositions comprising at least two different adjuvants and a therapeutic agent, their production and use for the prevention and therapy of proliferative diseases, infectious diseases, vascular diseases, rheumatoid diseases, inflammatory diseases, immune diseases, in particular autoimmune diseases and allergies.
(FR): L'invention porte sur un liposome, sur des mélanges ou des liposomes et des compositions liposomales comprenant au moins deux adjuvants différents et un agent thérapeutique, sur leur production et leur utilisation dans la prévention et la thérapie de maladies prolifératives, de maladies infectieuses, de maladies vasculaires, de maladies rhumatoïdes, de maladies inflammatoires et de maladies immunes, en particulier de maladies auto-immunes et d'allergies.

International search report:
Received at International Bureau: 06 April 2005 (06.04.2005) [EP]

International Report on Patentability (IPRP) Chapter II of the PCT:
Not available

(81) Designated States:
AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
European Patent Office (EPO) : AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR
African Intellectual Property Organization (OAPI) : BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG
African Regional Intellectual Property Organization (ARIPO) : BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW
Eurasian Patent Organization (EAPO) : AM, AZ, BY, KG, KZ, MD, RU, TJ, TM